Cerveau Technologies
Thom Tulip has long experience in Medical Imaging Pharmaceuticals and held roles of increasing responsibility at DuPont, BMS, Lantheus, Alseres, Navidea (Pres.& COO) and Fluoropharma (Pres. & CEO). He established and led the multidisciplinary PET group at MITA (The Medical Imaging Technology Assn.) and serves on the Executive Comm. of MITA’s Board of Directors.
This person is not in any offices
Cerveau Technologies
Cerveau Technologies focused on providing information and technologies to researchers and clinicians to improve brain health.